The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study
Open accessAbstract
COVID-19 is an unprecedented pandemic posing major threat to global public health. In the past decades of years or so, one could have heard of how dangerous it is to be virtually reliant on medicine supply from other countries. Nonetheless, no action was taken because it seemed to many that the global trade system was operational and Nigerians as well as citizens of African countries appear to have sufficient supply of the medications required at quite appealing cost. Currently in 2020, this apprehension has revolved from an imaginary problem to an actual challenge that might have consequences for millions nationwide due to COVID-19 pandemic. Now, African countries can realize that putting all our eggs in one basket was not such a good idea. In Nigeria, over 70% of the prescribed medications are produced from active ingredients (API) primarily sourced from firms in China and India. Access to medicine is an integral part of healthcare systems, uninterrupted access to medicine is much needed and essential for the well-being of the population. We are now approaching the conclusion that it is more reasonable to probably invest a little more to resuscitate a domestic pharmaceutical synthesis and herbal medicine research capacity in Nigeria and across African countries to improve public health.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The challenges in Nigeria and other countries like Taiwan have been further complicated by the COVID-19 pandemic.
“It is important to note that the challenges in Nigeria and other countries like Taiwan have been further complicated by the COVID-19 pandemic [46, 47].”
From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
COVID-19 and Nigeria: putting the realities in context
Ohia, C., Bakarey, A. S., & Ahmad, T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.062 · Cited by 158 · see citing works
Current efforts and challenges facing responses to 2019-nCoV in Africa
Lucero‐Prisno, D. E., Adebisi, Y. A., & Xu, L. (2020) · Global Health Research and Policy · doi:10.1186/s41256-020-00148-1 · Cited by 126 · see citing works
Self-citationThe economic impact of substandard and falsified antimalarial medications in Nigeria
Beargie, S. M., Higgins, C. R., Evans, D. R., Laing, S., Erim, D., & Ozawa, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217910 · Cited by 82 · see citing works
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
Garuba, H. A., Köhler, J. C., & Huisman, A. M. (2009) · Globalization and Health · doi:10.1186/1744-8603-5-14 · Cited by 63 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Burt, J., Ouma, J., Lubyayi, L., Amone, A., Aol, L., Sekikubo, M., Nakimuli, A., Nakabembe, E., Mboizi, R. B., Musoke, P., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006102 · Cited by 180 · see citing works
Okereke, M., Ukor, N. A., Adebisi, Y. A., Ogunkola, I. O., Favour Iyagbaye, E., Adiela Owhor, G., & Lucero‐Prisno, D. E. (2021) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3067 · Cited by 167 · see citing works
Self-citationAdebisi, Y. A., Jimoh, N. D., Ogunkola, I. O., Uwizeyimana, T., Olayemi, A. H., Ukor, N. A., & Lucero‐Prisno, D. E. (2021) · Tropical Medicine and Health · doi:10.1186/s41182-021-00344-w · Cited by 147 · see citing works
Self-citationRevisiting the issue of access to medicines in Africa: Challenges and recommendations
Adebisi, Y. A., Nwogu, I. B., Alaran, A. J., Badmos, A. O., Bamgboye, A. O., Rufai, B. O., Okonji, O. C., Malik, M. O., Teibo, J. O., Abdalla, S. F., et al. (2022) · Public Health Challenges · doi:10.1002/puh2.9 · Cited by 111 · see citing works
Self-citationMedicines and vaccines supply chains challenges in Nigeria: a scoping review
Olutuase, V. O., Iwu-Jaja, C. J., Akuoko, C. P., Adewuyi, E. O., & Khanal, V. (2022) · BMC Public Health · doi:10.1186/s12889-021-12361-9 · Cited by 99 · see citing works
Impact of the COVID-19 Pandemic on Consumers’ Access to Essential Medicines in Nigeria
Awucha, N. E., Ofomata, C. J., Meshach, A. C., Jibuaku, C. H., Daniel, A. I., & Chidiebere, N. E. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0838 · Cited by 86 · see citing works
Rural communities in Africa should not be forgotten in responses to COVID ‐19
Ogunkola, I. O., Adebisi, Y. A., Imo, U. F., Odey, G. O., Esu, E., & Lucero‐Prisno, D. E. (2020) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3039 · Cited by 84 · see citing works
Self-citationAntibiotic Resistance and Its Impact on Disease Management
Nadgir, C. A., & Biswas, D. A. (2023) · Cureus · doi:10.7759/cureus.38251 · Cited by 56 · see citing works
Drug shortage crisis in Sudan in times of COVID-19
Lucero‐Prisno, D. E., Elhadi, Y. A. M., Modber, M. A. K. A., Musa, M. B., Mohammed, S. E. E., Hassan, K. F., Dafallah, A., Xu, L., Ahmadi, A., Adeyemi, S., et al. (2020) · Public Health in Practice · doi:10.1016/j.puhip.2020.100060 · Cited by 46 · see citing works
Self-citationDrug supply situation in Rwanda during COVID-19: issues, efforts and challenges
Uwizeyimana, T., Hashim, H. T., Kabakambira, J. D., Mujyarugamba, J. C., Dushime, J., Ntacyabukura, B., Ndayizeye, R., Adebisi, Y. A., & Lucero‐Prisno, D. E. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00301-2 · Cited by 42 · see citing works
Self-citationChilot, D., Woldeamanuel, Y., & Manyazewal, T. (2021) · Annals of Global Health · doi:10.5334/aogh.3481 · Cited by 37 · see citing works
COVID‐19 calls for health systems strengthening in Africa: A case of Nigeria
Elebesunu, E. E., Oke, G. I., Adebisi, Y. A., & Nsofor, I. M. (2021) · The International Journal of Health Planning and Management · doi:10.1002/hpm.3296 · Cited by 36 · see citing works
Self-citationDrug supply shortage in Nigeria during COVID-19: efforts and challenges
Faiva, E., Hashim, H. T., Ramadhan, M. A., Musa, S. K., Bchara, J., Tuama, Y. D., Adebisi, Y. A., Kadhim, M. H., Essar, M. Y., Ahmad, S., et al. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00302-1 · Cited by 36 · see citing works
Self-citationHow West African countries prioritize health
Adebisi, Y. A., Alaran, A. J., Badmos, A. O., Bamisaiye, A., Nzeribe, E. C., Etukakpan, A. U., Oladunjoye, I. O., Oladipo, O., Musa, S. K., Akinmuleya, T., et al. (2021) · Tropical Medicine and Health · doi:10.1186/s41182-021-00380-6 · Cited by 34 · see citing works
Self-citationEjekam, C. S., Emeje, M. O., Lukulay, P. H., Uche, C. R., Odibeli, O., Sanusi, O., & Anyakora, C. (2023) · Journal of Public Health Policy · doi:10.1057/s41271-023-00405-w · Cited by 32 · see citing works
Deveci, M., Krishankumar, R., Gökaşar, I., & Deveci, R. T. (2022) · Annals of Operations Research · doi:10.1007/s10479-022-04714-3 · Cited by 24 · see citing works
Early geography of the coronavirus disease outbreak in Nigeria
Olusola, A. O., Olusola, B. A., Onafeso, O. D., Ajiola, F. O., & Adelabu, S. A. (2020) · GeoJournal · doi:10.1007/s10708-020-10278-1 · Cited by 23 · see citing works
Bello, S., Neill, R., Jegede, A. S., Bamgboye, E. A., Salawu, M. M., Afolabi, R. F., Nzelu, C. E., Azodo, N., Adoghe, A., Ogunlayi, M., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11072-2 · Cited by 20 · see citing works
Adigwe, O. P., Onavbavba, G., & Wilson, D. O.-M. (2022) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s387354 · Cited by 17 · see citing works
COVID-19 in Nigeria: Is the pharmaceutical sector spared?
Akande‐Sholabi, W., Adebisi, Y. A., Bello, A. E., & Ilesanmi, O. S. (2020) · Public Health in Practice · doi:10.1016/j.puhip.2020.100044 · Cited by 15 · see citing works
Self-citationGlobal Impact of COVID-19 Pandemic on Public Health Supply Chains
Okafor, U. G., Olaleye, M. A., Asobara, H. C., & Umeodinka, E. F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97454 · Cited by 15 · see citing works
COVID-19 and the impact of cash transfers on health care use in Togo
Tossou, Y. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06895-2 · Cited by 14 · see citing works
Elsafty, A., & Osman, M. (2021) · International Journal of Business and Management · doi:10.5539/ijbm.v16n7p57 · Cited by 13 · see citing works
Towards an inclusive health agenda: people who inject drugs and the COVID-19 response in Africa
Adebisi, Y. A., & Lucero‐Prisno, D. E. (2020) · Public Health · doi:10.1016/j.puhe.2020.10.017 · Cited by 13 · see citing works
Self-citationAjayi-Lowo, E. O. (2024) · Meridians · doi:10.1215/15366936-10926960 · Cited by 12 · see citing works
Empiric Antibiotics in COVID 19: A Narrative Review
Lingas, E. C. (2022) · Cureus · doi:10.7759/cureus.25596 · Cited by 10 · see citing works
Odusanya, O. O. (2022) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_106_22 · Cited by 10 · see citing works
Pedagogy and innovative care tenets in COVID-19 pandemic: An enhancive way through Dentistry 4.0
Javaid, M., Haleem, A., Singh, R. P., & Suman, R. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100118 · Cited by 9 · see citing works
Ensuring access to COVID-19 vaccines among marginalised populations in Africa
Lucero‐Prisno, D. E., Adebisi, Y. A., Uzairue, L. I., Abdullahi, A., Alaran, A. J., Izukanne, E. E., Jamgbadi, O. F., & Bolarinwa, O. A. (2021) · Public Health · doi:10.1016/j.puhe.2021.01.008 · Cited by 9 · see citing works
Self-citationEmpowering health sovereignty in Africa through innovations for self-reliant healthcare
Abdullahi, Y. B., Ahmed, N., Bashir, S., Abdi, Y. H., Abdi, M. S., Alhammadi, O. A. S., Okesanya, O. J., Agboola, A. O., & Ahmed, M. M. (2025) · Discover Public Health · doi:10.1186/s12982-025-01184-3 · Cited by 11 · see citing works
Adigwe, O. P., & Oturu, D. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000683 · Cited by 8 · see citing works
Nurses’ Lived Experiences of Caring for Patients with COVID-19 in Nigeria
Popoola, T., Popoola, V. O., & Nelson, K. (2022) · SAGE Open Nursing · doi:10.1177/23779608221117384 · Cited by 8 · see citing works
Pharmacoeconomics in Africa: needs, prospect and challenges
Ajepe, T. B., Nwogu, I. B., Olaoye, D. Q., Mustapha, A. A., Uwizeyimana, T., & Adebisi, Y. A. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00328-5 · Cited by 5 · see citing works
Self-citationAkinyemi, P. A., Owoade, I. A., Fajobi, O., Wuraola, F. O., & Elugbaju, O. (2021) · Journal of Community Medicine and Primary Health Care · doi:10.4314/jcmphc.v33i2.1 · Cited by 5 · see citing works
Merga, B. T., Ayana, G. M., Negash, B., Alemu, A., Abdurke, M., Abdu, A., Balis, B., Bekana, M., Fekadu, G., & Raru, T. B. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s361199 · Cited by 6 · see citing works
The Effect of Using Applications to Facilitate Medicine Purchase Amid the Covid-19 Pandemic
Departemen Manajemen, U. K. I., Soegoto, E. S., Alifia, N. T., Salsabila, T., & Mardika, C. N. (2022) · International Journal of Research and Applied Technology · doi:10.34010/injuratech.v2i1.6621 · Cited by 5 · see citing works
Nigeria’s Media Framing of COVID – 19 Pandemic: A Content Analysis of Selected National Dailies
Aderogba, A. (2021) · World Scientific News · Cited by 4 · see citing works
COVID-19 and the Impact of Cash Transfers on Health Care Use in TogoPreprint
Tossou, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-145956/v1 · Cited by 3 · see citing works
Identifying the Gaps in HIV Prevention and Treatment During the COVID-19 Pandemic in Nigeria
Bassey, A. E., Olisaeloka, L., & Adebisi, Y. A. (2020) · International Journal of Infection · doi:10.5812/iji.109546 · Cited by 2 · see citing works
Self-citationThe Development of Healthcare Jobs in the COVID-Pandemic—A New Economic Market
Bachmann, M., Enodien, B., Frey, D. M., Taha‐Mehlitz, S., & Taha, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.848636 · Cited by 2 · see citing works
Towards 90-90-90 Target: COVID-19 and HIV Response in Africa
Adebisi, Y. A., Adrian, R., Ekpenyong, A. M., Okereke, M., Atieno, S. O., Oladunni, A. A., Micheal, A. I., Amusile, O., Olaoye, D. Q., Bamisaiye, A., et al. (2021) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510191 · Cited by 2 · see citing works
Self-citationNeto, M. N. F., Forte, S. H. A. C., Juliao, F., & Viana, C. M. G. (2021) · International Journal of Business Economics and Management · doi:10.18488/journal.62.2021.83.165.180 · Cited by 1 · see citing works
Assessing the Economic and Security Shocks of COVID-19 Lockdowns in Nigeria
Akeju, K. F., & Akpabio, E. S. (2023) · Springer eBooks · doi:10.1007/978-3-030-68127-2_343-1 · Cited by 1 · see citing works
Olayisade, A. (2025) · doi:10.33774/coe-2025-zn667 · Cited by 1 · see citing works
The COVID-19 response in Nigeria: Adequate protection of a fragile healthcare delivery system
Kola-Mustapha, A. T., Ubani-Ukoma, U. N., Ilomuanya, M. O., & Nnamani, P. O. (2021) · Nigerian Journal of Pharmacy · doi:10.51412/psnnjp.2021.2
Perspectives of COVID-19 Survivors on the Treatment Experience in Nigeria
Kusimo, O. C., Ogiri, S., Adamu, H. I., & Aduh, U. (2022) · OALib · doi:10.4236/oalib.1108373
Wu, F. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v45i.7297 · Cited by 1 · see citing works
Adegboyega, K., & Aliyu, I. Y. (2023) · Caleb International Journal of Development Studies · doi:10.26772/cijds-2023-06-02-08
Current Trends in Biosynthesis, Extraction, Purification, and Refining of Antibiotics
Irfan, M., Bibi, F., & Saeed, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-50989-6_12
Differential Impact of the COVID-19 Pandemic on Education in Nigeria: Implications for Policy ReviewPreprint
Omotoso, K. O., Adewole, O. G., & Gbadegesin, T. F. (2025) · doi:10.12688/verixiv.211.1
Differential Impact of the COVID-19 Pandemic on Education in Nigeria: Implications for Policy ReviewPreprint
Omotoso, K. O., Adewole, O. G., & Gbadegesin, T. F. (2025) · doi:10.12688/verixiv.211.2
Correlates of Emergency Preparedness and Response to Disease Outbreaks in Kano, Northwest Nigeria
Danzomo, A. A., Kofi, B., Audu, S., Ibrahim, U. M., Ismail, T., Bawa, J. A., Abbas, M. A., Alhassan, S. U., Ibrahim, S. A., & Akyala, A. I. (2025) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_317_25
COVID-19, Law Enforcement, and Lockdown in Northern Nigeria
Sule, B., & Sambo, U. (2025) · Southern African Journal of Security · doi:10.25159/3005-4222/19041
Prevalence and risk factors of home delivery among rural women: evidence from 28 African countries
Armah‐Ansah, E. K., Okeke-Obayemi, D. O., Okeke, S. R., Budu, E., Omenka, C. O., & Ameyaw, E. K. (2026) · Reproductive Health · doi:10.1186/s12978-026-02386-x
Adigwe, O. P., Onavbavba, G., Alabi, T. F., & Uzuh, N. R. (2026) · Health Science Reports · doi:10.1002/hsr2.72624
Mbanya, V. N., de Jong, A. J., Ndayishimiye, P., Vattekar, S. W., Nambasa, V. P., Chambiri, S. M., Ddamulira, C., Opolot, H., Batera, J., Ndagije, H. B., et al. (2026) · Open Research Europe · doi:10.12688/openreseurope.24694.1
- Authors
- Akande-Sholabi, W., & Adebisi, Y. A.
- Affiliations
- University of Ibadan (NG)
- Venue
- The Pan African Medical Journal
- Publisher
- Pan African Medical Journal
- Published
- 2020-06-10
- Volume
- 35
- Issue
- Supp 2
- Pages
- 73-73
- ISSN
- 1937-8688 (ISSN-L)
- PMC
- PMC7875805
- OpenAlex
- W3040017138
- Cited by
- 56
- References
- 4
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 12 · 2021: 19 · 2020: 8
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Pan African Medical Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Social Sciences › Political Science and International Relations › COVID-19, Geopolitics, Technology, Migration
- Keywords
- COVID-19 pandemic, pharmaceutical supply chain, active pharmaceutical ingredients, import dependence, herbal medicine research, access to medicines, Nigeria, Africa
- MeSH terms
- COVID-19, Delivery of Health Care, Pharmaceutical Preparations, Health Services Accessibility, Humans, Nigeria, Public Health, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
